Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2008
09/04/2008US20080214626 Methods for prevention and treatment of diseases causes by hypertension
09/04/2008US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators
09/04/2008US20080214600 Quaternized Quinuclidine Esters
09/04/2008US20080214598 Novel Piperidine Carboxylic Acid Amide Derivatives
09/04/2008US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics
09/04/2008US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction
09/04/2008US20080214524 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity
09/04/2008US20080213886 Albumin fusion proteins
09/04/2008US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders
09/04/2008CA2679126A1 Macrocyclic compound
09/03/2008EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/03/2008EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/03/2008EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals
09/03/2008EP1964839A2 Quinazoline derivatives as kinase inhibitors
09/03/2008EP1964566A1 Preparation with improved bioabsorbability of sapropterin hydrochloride
09/03/2008EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
09/03/2008EP1962855A2 Trpa1 inhibitors for treating pain
09/03/2008EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
09/03/2008EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses
09/03/2008EP1448234B1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs
09/03/2008EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/03/2008CN101255162A Adenosine receptor antagonists and methods of making and using the same
09/03/2008CN101254279A Yiyuan long life health care Chinese medicine
09/03/2008CN101254260A Pharmaceutical combination for curing prostate gland hyperplasy, anuresis and preparation thereof
09/03/2008CN101254242A Applications of Chinese medicinal composition for preparing inhibition angiotensin II receptor
09/03/2008CN101254184A Salviol acid B phosphatide complexes and method of preparing the same
09/03/2008CN100415747C Phosphodiesterase 4 inhibitors
09/03/2008CN100415724C Pyrimidine derivatives
09/03/2008CN100415718C CASPASE inhibitors and use thereof
09/03/2008CN100415257C Application of peru apple in preparation of medicine
09/03/2008CN100415256C Chinese traditional medicine preparation for treating uremia
09/03/2008CN100415239C Highly concentrated solution of finasteride and use thereof
09/03/2008CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420053 2-imino-1,3-thiazine derivatives
09/02/2008US7420050 TGF-β-specific covalently closed antisense molecule
09/02/2008US7420029 A tissue-specific transporter function inhibitor has both a ligand structure recognized by a tissue-specific transporter and a polymeric molecular structure incapable of passing through a membrane tissue
09/02/2008US7419999 Gamma lactams as prostaglandin agonists and use thereof
09/02/2008US7419998 Therapeutic methods and compositions involving isoflavones
09/02/2008US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds
09/02/2008US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
09/02/2008US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
09/02/2008US7419950 Methods of inhibiting ectopic calcification
09/02/2008US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation
09/02/2008US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant
09/02/2008CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent
08/2008
08/28/2008WO2008103847A2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
08/28/2008WO2008102777A1 Ameliorating agent for insulin resistance
08/28/2008WO2008102749A1 Heterocyclic compound
08/28/2008WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins
08/28/2008WO2007092720A8 Vitamin d analog: nel, methods and uses thereof
08/28/2008US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes
08/28/2008US20080207769 Method for treating benign prostatic hyperplasia
08/28/2008US20080207768 Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom
08/28/2008US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents
08/28/2008US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound
08/28/2008US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
08/28/2008US20080207664 Uniform concentration in blood ; oral administering
08/28/2008US20080207655 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents
08/28/2008US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207545 Using antisense oligonucleotides, small interfering RNA, and ribozymes to inhibit expression of the human steroid 5 alpha-reductase gene and thereby inhibit formation of dihydrotestosterone: skin diseases, hair loss, hirsuitism, and benign prostatic hyperplasia
08/28/2008US20080206338 Controlled release formulations of an alpha-adrenergic receptor antagonist
08/28/2008CA2678757A1 Ameliorating agent for insulin resistance
08/27/2008EP1961756A1 Novel bisboron compound
08/27/2008EP1961751A1 Acid addition salt of optically active dihydropyridine derivative
08/27/2008EP1961749A1 Acid addition salt of dihydropyridine derivative
08/27/2008EP1961420A1 Agent for prevention and treatment of acute renal failure
08/27/2008EP1961418A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer
08/27/2008EP1961309A1 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof
08/27/2008EP1660484B1 Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
08/27/2008EP1337560B1 Truncated cd200
08/27/2008EP1313714B1 Valsartan salts
08/27/2008EP1234025B1 Human enzymes of the metalloprotease family
08/27/2008EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease
08/27/2008EP1089994B9 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
08/27/2008CN101253159A Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/27/2008CN101250136A 1,3-diaryl-3-aryl amidine-1-acetoxime compounds, preparation method and use thereof
08/27/2008CN101250134A N-aryl-beta-aryl amidine-propionamide compounds, preparation method and use thereof
08/27/2008CN101249261A Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same
08/27/2008CN101249258A An uro-genital condition treatment system
08/27/2008CN101249239A Traditional Chinese medicine preparation for curing chyluria
08/27/2008CN101249231A Medicine composition for treating lithiasis and preparation thereof
08/27/2008CN101249229A Chinese medicine preparation for curing bloody stranguria type cystitis
08/27/2008CN101249178A Reinforced immunity and kidney tonifying health care medicinal liquor and preparing same thereof
08/27/2008CN101249171A Calculi discharging medicament
08/27/2008CN101249170A Preparation of houttuynia cordata freeze-dried powder needle for injections
08/27/2008CN101249168A Traditional Chinese medicine preparation for curing heat stranguria
08/27/2008CN101249135A Compound urolithic stranguria unlock capsules and preparation technique thereof
08/27/2008CN101248863A Method for processing medlar bud appetizer food
08/27/2008CN100413885C Modified proteins, designer toxins and methosd of making thereof
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/27/2008CN100413852C Valsartan salts
08/27/2008CN100413531C Chinese medicine preparation for treating calculus
08/26/2008US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring
08/26/2008US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone
08/26/2008US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases
08/26/2008US7416848 DNA encoding SNORF25 receptor
08/26/2008US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein.